69 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #AACE #2018 # ... Control #Medication #Algorithm ... #PrimaryCare #Management
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Beta-blocker • ACE ... Heart #Failure #CHF ... HFrEF #Guideline #management ... #GDMT #cardiology
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Stepwise Approach: ACE ... Heart #Failure #CHF ... HFrEF #Guideline #management ... #GDMT #cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ACEI indicates angiotensin-converting ... ejection fraction; GDMT ... #CHF #Congestive ... Stages #ACCAHA #Algorithm ... #Management #Cardiology
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
Must Be On" • ACEI ... Reducing: • ACEI ... patients #hfref #management ... #medications #chf ... #cardiology #GDMT
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
HFrEF) Treatment - GDMT ... Medical Therapy (GDMT ... GDMT is basically ... /ambcarerx #CHF ... #Pharmacology #Management
Recommended Therapeutic Approach to the Patient with Hypertrophic Cardiomyopathy (HOCM)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers;
Cardiomyopathy (HOCM) ACE ... receptor blockers; HF ... Cardiomyopathy #Algorithm ... #Management #Cardiology
Guidelines Directed medical therapy for Heart Failure 

Satyendra Dhar, MD, @DharSaty

#HFrEF #GDMT #sodium-glucosecotransporter-2inhibitors #SGLT2i #reninangiotensinaldosteronesysteminhibitors
DharSaty #HFrEF #GDMT ... AngiotensinReceptorNeprilysinInhibitor #ACEi ... ARNI #PARADIGM-HF
AACE/ACE ASCVD Risk Factor Modifications Algorithm

#ASCVD #RiskFactor #Modifications #Algorithm #Management #AACE
AACE/ACE ASCVD Risk ... Modifications Algorithm ... Modifications #Algorithm ... #Management #AACE
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
for SGLT2i in HF ... for SGLT2i in HF ... had no effect on MACE ... in HFrEF on GDMT ... outcomes in HFrEF on GDMT